These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18992277)

  • 21. Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.
    Chu PW; Hadlock GC; Vieira-Brock P; Stout K; Hanson GR; Fleckenstein AE
    J Neurochem; 2010 Oct; 115(2):325-32. PubMed ID: 20649837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an α-synuclein-dependent mechanism.
    Chadchankar H; Ihalainen J; Tanila H; Yavich L
    J Pharmacol Exp Ther; 2012 May; 341(2):484-92. PubMed ID: 22344407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.
    Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
    Synapse; 2009 Feb; 63(2):147-51. PubMed ID: 19021208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content.
    Bemis JC; Seegal RF
    Toxicol Sci; 2004 Aug; 80(2):288-95. PubMed ID: 15115888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
    Simchon Y; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):714-20. PubMed ID: 20493667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.
    Riddle EL; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2007 Sep; 571(1):25-8. PubMed ID: 17618619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum.
    Pifl C; Rajput A; Reither H; Blesa J; Cavada C; Obeso JA; Rajput AH; Hornykiewicz O
    J Neurosci; 2014 Jun; 34(24):8210-8. PubMed ID: 24920625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.
    Truong JG; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2004 May; 492(2-3):143-7. PubMed ID: 15178358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration.
    Truong JG; Rau KS; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2003 Aug; 474(2-3):223-6. PubMed ID: 12921866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
    Truong JG; Newman AH; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2004 Nov; 504(1-2):27-32. PubMed ID: 15507217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.
    Wooters TE; Bardo MT; Dwoskin LP; Midde NM; Gomez AM; Mactutus CF; Booze RM; Zhu J
    Behav Brain Res; 2011 May; 219(1):98-107. PubMed ID: 21219939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylphenidate sensitization is prevented by prefrontal cortex lesion.
    Lee MJ; Swann AC; Dafny N
    Brain Res Bull; 2008 May; 76(1-2):131-40. PubMed ID: 18395622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine.
    Lee NR; Zheng G; Leggas M; Janganati V; Nickell JR; Crooks PA; Bardo MT; Dwoskin LP
    J Pharmacol Exp Ther; 2019 Nov; 371(2):526-543. PubMed ID: 31413138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications.
    Hanson GR; Sandoval V; Riddle E; Fleckenstein AE
    Ann N Y Acad Sci; 2004 Oct; 1025():146-50. PubMed ID: 15542712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K(+)-stimulated dopamine release in frozen rat brain tissue.
    Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2009 Jun; 180(2):317-20. PubMed ID: 19464519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
    Freyberg Z; Sonders MS; Aguilar JI; Hiranita T; Karam CS; Flores J; Pizzo AB; Zhang Y; Farino ZJ; Chen A; Martin CA; Kopajtic TA; Fei H; Hu G; Lin YY; Mosharov EV; McCabe BD; Freyberg R; Wimalasena K; Hsin LW; Sames D; Krantz DE; Katz JL; Sulzer D; Javitch JA
    Nat Commun; 2016 Feb; 7():10652. PubMed ID: 26879809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles.
    Cartier EA; Parra LA; Baust TB; Quiroz M; Salazar G; Faundez V; Egaña L; Torres GE
    J Biol Chem; 2010 Jan; 285(3):1957-66. PubMed ID: 19903816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
    Eyerman DJ; Yamamoto BK
    J Neurochem; 2007 Nov; 103(3):1219-27. PubMed ID: 17683483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.